News & insights

Thoughts

EU regulatory exclusivity changes: The increasing importance of patent monopolies for pharma

The regulatory data exclusivity and market protection regime in the European Union is changing.

Thoughts

R 12/21: Petition for review succeeds after EPO Board of Appeal found to violate right to be heard

The petition for review procedure under Article 112a EPC allows parties adversely affected by a decision of the Board of Appeal (BoA) to request a review by the Enlarged Board of Appeal (EBoA). The ba...

CRISPR

The CRISPR therapeutics landscape in 2025

Once confined to science fiction, precise genetic engineering has become a reality and has profoundly impacted modern medicine.

Case law

Dosage regimen patents at the EPO part (II): Recent case law

Dosage regimen patent applications are typically filed a few years after the original application to compounds and their medical uses. Often a clinical trial will already be underway, investigating di...

Technical Tips

Dosage regimen patents at the EPO part (I): Strategic tips for success

Dosage regimen claims typically refer to compounds for use in treating a condition at a specific frequency of administration, at a specific dose or within a specific dosage range. Sometimes further fe...

Case law

Sanofi vs Amgen: The UPC decides on second medical use claims

The Dusseldorf local division has last week handed down the first decision from the UPC relating to second medical use claims. Here, we discuss what can be gleaned from this first instance decision re...

Case law

Challenges of extending expired patent rights through trade marks in the medical implant market: Insights from AG Biondi’s Opinion in Case C-17/24

Trade marks can offer very powerful complementary and long-lasting benefits for companies once their patents expire. The term of protection of a patent can give its owner a precious period in which to...

Thoughts

How RNA therapeutics are shaping the future of mental health treatment

This Mental Health Awareness Week, we wanted to highlight how the fast-moving field of RNA therapeutics is being leveraged to treat mental health disorders such as anxiety and depression. We will cove...

Thoughts

Requesting a Unitary Patent – What do I need to know?

Since the changes to the European patent system which led to the introduction of the Unitary Patent (UP) and the Unified Patent Court (UPC), we have been assisting more and more clients with obtaining...

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us